Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio (2010 - 2026)
Ironwood Pharmaceuticals' (IRWD) quarterly Interest Coverage Ratio came in at 11.01 in Q2 2026, up 103.0% year-over-year from 5.42 in Q2 2025, and up 38.68% quarter-over-quarter from 7.94 in Q1 2026.
Analysis
Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Interest Coverage Ratio across 17 years of filings, most recently posting 11.01 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio rose 103.0% year-over-year to 11.01; the TTM figure through Jun 2026 stood at 7.17 (up 239.77% YoY), while the FY2025 annual figure was 3.01, up 6.71% from the prior year.
- Interest Coverage Ratio came in at 11.01 for Q2 2026 at Ironwood Pharmaceuticals, up from 7.94 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 44.93 in Q3 2022 to a low of 588.66 in Q2 2023.
- Average Interest Coverage Ratio over 5 years is 19.97, with a median of 4.94 recorded in 2023.
- Year-over-year, Interest Coverage Ratio surged 529.41% in 2022 and tumbled 2434.34% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 44.8 in 2022, then plunged by 90.04% to 4.46 in 2023, then decreased by 20.84% to 3.53 in 2024, then plunged by 75.57% to 0.86 in 2025, then jumped by 1175.93% to 11.01 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 11.01 in Q2 2026, 7.94 in Q1 2026, and 0.86 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - | 11.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.01 |
| Mar 31, 2026 | 7.94 |
| Dec 31, 2025 | 0.86 |
| Sep 30, 2025 | 8.95 |
| Jun 30, 2025 | 5.42 |
| Mar 31, 2025 | -3.61 |
| Dec 31, 2024 | 3.53 |
| Sep 30, 2024 | 2.72 |
| Jun 30, 2024 | 3.34 |
| Mar 31, 2024 | 1.52 |
| Dec 31, 2023 | 4.46 |
| Sep 30, 2023 | 4.07 |
| Jun 30, 2023 | -588.66 |
| Mar 31, 2023 | 39.36 |
| Dec 31, 2022 | 44.80 |
| Sep 30, 2022 | 44.93 |
| Jun 30, 2022 | 25.22 |
| Mar 31, 2022 | 24.71 |
| Dec 31, 2021 | 7.12 |
| Sep 30, 2021 | 8.31 |